CANDI'ACTIV 3
Food supplement declared in France, declaration No 2018-7-706
CANDI'ACTIV 3 is a food supplement declared in France. Status: retiré du marché le 20 September 2024. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- GREEN TIME SA
- Status
- Retiré du marché le 20 September 2024
- Form
- Gélule
- Daily dose
- 3 gélules par jour
- Directions for use
- Prendre 1 gélule 3 fois par jour pendant 10 jours au milieu des repas
- Not recommended for (according to the manufacturer)
- Antécédent de cancer du sein
- Objectives stated by the manufacturer (these are not authorised claims)
- Immunité
Declaration 156817, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 20 September 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Olea europaea L. | Feuille | Poudre (de plantes séchées ou broyées) | 360 mg |
| Coriandrum sativum L. | Graine | Poudre (de plantes séchées ou broyées) | 225 mg |
| Satureja hortensis L. | Feuille | Extrait sec aqueux | 120 mg |
| Medicago sativa L. | Feuille | Extrait sec aqueux | 75 mg |
| Acacia senegal (L.) Willd. | Gomme | Poudre (de plantes séchées ou broyées) | 45 mg |
| Tanacetum parthenium (L.) Sch.Bip. | Parties aériennes | Extrait sec aqueux | 45 mg |
Additives
Hydroxypropyl Méthyl Cellulose
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux femmes ayant des antécédents personnels ou familiaux de cancer du sein.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Candi'Activ 3 BIOPHENIX, declared in 2025 : different composition: 6 ingredient(s) added, 6 missing
- Candi'Activ3 Biophenix, declared in 2023 : different composition: 4 ingredient(s) added, 5 missing
- CANDI'ACTIV 3 Biophénix, declared in 2022, withdrawn from the market : different composition: 1 ingredient(s) added, 2 missing